Establishment of a cynomolgus macaque model of influenza B virus infection
- PMID: 20822788
- DOI: 10.1016/j.virol.2010.08.006
Establishment of a cynomolgus macaque model of influenza B virus infection
Abstract
Pathogenicity of influenza B virus was examined in cynomolgus macaques to establish a macaque model suitable for vaccine and antiviral drug development. We prepared influenza B viruses for inoculation with minimal passages after isolation from patients. Macaques inoculated with influenza B virus showed higher body temperature than that before infection for 6 to 12 days. Virus was detected in nasal, tracheal, and bronchial samples until 6 days after inoculation followed by an increase in neutralizing antibody. High levels of IL-6 and TNF-α in nasal swabs from the infected macaques were correlated with fever. Symptoms and duration of the viral replication would be sufficient to evaluate efficacy of vaccines and antiviral agents. In addition, measurement of immune responses including antibody and cytokine production would provide an immunological rationale in efficacy of vaccines and antiviral agents. The results suggest that cynomolgus macaques are appropriate model animals for research of influenza B virus.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.Vaccine. 2008 Jan 24;26(4):562-72. doi: 10.1016/j.vaccine.2007.11.031. Epub 2007 Dec 3. Vaccine. 2008. PMID: 18164788
-
Development and characterization of a live attenuated influenza B virus vaccine candidate.Vaccine. 2008 Feb 13;26(7):874-81. doi: 10.1016/j.vaccine.2007.12.022. Epub 2008 Jan 7. Vaccine. 2008. PMID: 18207290
-
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.Nature. 2007 Jan 18;445(7125):319-23. doi: 10.1038/nature05495. Nature. 2007. PMID: 17230189
-
In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system.Methods Find Exp Clin Pharmacol. 1998 Apr;20(3):185-92. Methods Find Exp Clin Pharmacol. 1998. PMID: 9646280 Review.
-
[Various sides of influenza, part I--structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics].Pol Merkur Lekarski. 2006 Sep;21(123):270-6. Pol Merkur Lekarski. 2006. PMID: 17163190 Review. Polish.
Cited by
-
The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.Antiviral Res. 2015 May;117:75-98. doi: 10.1016/j.antiviral.2015.02.011. Epub 2015 Mar 5. Antiviral Res. 2015. PMID: 25746173 Free PMC article. Review.
-
A comprehensive review of influenza B virus, its biological and clinical aspects.Front Microbiol. 2024 Sep 4;15:1467029. doi: 10.3389/fmicb.2024.1467029. eCollection 2024. Front Microbiol. 2024. PMID: 39296301 Free PMC article. Review.
-
Animal models for the risk assessment of viral pandemic potential.Lab Anim Res. 2020 Apr 22;36:11. doi: 10.1186/s42826-020-00040-6. eCollection 2020. Lab Anim Res. 2020. PMID: 32337177 Free PMC article. Review.
-
Non-human primate models of human respiratory infections.Mol Immunol. 2021 Jul;135:147-164. doi: 10.1016/j.molimm.2021.04.010. Epub 2021 Apr 23. Mol Immunol. 2021. PMID: 33895579 Free PMC article. Review.
-
Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques.J Virol. 2022 Aug 24;96(16):e0072822. doi: 10.1128/jvi.00728-22. Epub 2022 Aug 4. J Virol. 2022. PMID: 35924920 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical